Spots Global Cancer Trial Database for Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy

Official Title: Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy

Study ID: NCT03859804

Conditions

Pain Due to Certain Specified Procedures

Prostate Cancer

Biopsy

Interventions

Standard transrectal 12 core biopsy

MRI- US fusion prostate biopsy (FPB)

Study Description

Brief Summary: The aim of this study was to compare the pain levels in transrectal ultrasound (TRUS)-guided standard 12-core prostate biopsy (SPB) and multiparametric prostate magnetic resonance imaging (MpMRI)-guided fusion prostate biopsy (FPB).

Detailed Description: The study included patients that underwent prostate biopsy under local anesthesia (intrarectal 2% lidocaine gel + periprostatic nerve block) due to suspected prostate cancer. Patients detected with a Prostate Imaging Reporting and Data System score (PIRADS) ≥3 lesion on MpMRI underwent MpMRI-guided FPB (Group I) and the patients who had no suspected lesions or had a PI-RADS \<3 lesion on MpMRI underwent TRUS-guided SPB (Group II). Pain assessment was performed using Visual Analog Scale (VAS) 5 min after the procedure. Following the procedure, the patients were asked to indicate the most painful biopsy step among the three steps (1: insertion of the probe into the rectum, 2: probe manipulation, 3: the piercing of the biopsy needle).